𝔖 Bobbio Scriptorium

✦ LIBER ✦

Lamivudine facilitates chemotheraphy in children with haematological malignancies and chronic HBV (CHB)

✍ Scribed by M.H. El-Sayed; G. Shanab; A. Karim; P. Roopram; A. Black

Book ID: 119527449
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 126 KB
Volume: 34
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(01)81494-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1151 An extended, stratified, follow-on

1151 An extended, stratified, follow-on study in children with chronic hepatitis B (CHB) who have completed previous lamivudine studies

✍ SOKAL, E; MIZERSKI, J; WOYNAROWSKI, M; SLUZEWSKI, W; BADIA, I; KELLY, D; SCHWARZ 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

438 Continued safety and efficacy of add

438 Continued safety and efficacy of adding adefovir dipivoxil (ADV) to ongoing lamivudine (LAM) therapy in compensated chronic hepatitis B (CHB) patients with YMDD variant HBV: 2 year results

✍ R. Perrillo; B. Willems; N. Leung; C. Trepo; H.W.L. Hann; G. Lau; W.M. Lee; E. S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Two years results of lamivudine (LMV) al

Two years results of lamivudine (LMV) alone and LMV plus interferon (IFN) treatment in children with chronic hepatitis B (CHB) who were non-responders to IFN

✍ I.N. Saltik Temizel; N. Kocak; H. Demir; H. Ozen; F. Gurakan; A. Yuce 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 321 KB

P.107 Variant strains of HBV contribute

P.107 Variant strains of HBV contribute to clinical outcome of combination therapy with lamivudine and interferon-alpha in tolerant children with chronic hepatitis B

✍ I. Carey; M. Cavers; L. D'Antiga; Y. Ma; S. Bansal; J. Byrne; G. Mieli-Vergani; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 143 KB

502 A broad and strong HBV core-specific

502 A broad and strong HBV core-specific T cell reactivity characterizes sustained viral control in children with chronic hepatitis B treated with combined lamivudine and interferon-α

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

A follow-on study in children with chron

A follow-on study in children with chronic hepatitis B (CHB) who completed a placebo controlled lamivudine study - a 6-month interim analysis: Maureen M Jonas, Children's Hospital Boston, Boston, MA; Deirdre A Kelly, Diana Princess of Wales Hospital, Birmingham Uk; Jacek Mizerski, John Paul II Hospital, Krakow Poland; Isabel B Badia, Unidad IV, Hospital de Ninos, Buenos Aires Argentina; Jorge A Areias, Hospital Geral de Santo Antonio, Porto Portugal; Kathleen B Schwarz, John Hopkins University, Baltimore, MD; M S Bell, GlaxoSmithKline, Research Triangle Park, NC; Martin J Greensmith, GlaxoSmithKline, Greenford Uk; Nancy R Little, GlaxoSmithKline, Research Triangle Park, NC; Etienne M Sokal, Cliniques Universitaires St Luc, Burxelles Belgium

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB